HCW Biologics Inc. (HCWB) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
23/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinHCWB / S&P 131.02% / 15.20% |
WinHCWB / S&P 700.19% / 15.00% |
LoseHCWB / S&P -74.68% / 50.40% |
| 2026-Q12/3 |
LoseHCWB / S&P -62.92% / -4.33% |
WinHCWB / S&P 353.18% / 11.30% |
WinHCWB / S&P 67.38% / 27.70% |
| 2025-Q41/3 |
LoseHCWB / S&P -73.76% / 2.65% |
LoseHCWB / S&P -97.89% / 9.00% |
WinHCWB / S&P 90.31% / 13.40% |
| 2025-Q31/3 |
LoseHCWB / S&P -6.68% / 8.12% |
LoseHCWB / S&P -87.93% / 4.61% |
WinHCWB / S&P 127.71% / 13.45% |
| 2025-Q21/3 |
LoseHCWB / S&P -64.85% / 10.94% |
LoseHCWB / S&P -78.77% / 4.83% |
WinHCWB / S&P 194.35% / 10.63% |
| 2025-Q11/3 |
LoseHCWB / S&P -36.77% / -4.27% |
LoseHCWB / S&P -63.20% / 4.98% |
WinHCWB / S&P 3175.00% / 10.57% |
| 2024-Q41/3 |
LoseHCWB / S&P -17.25% / 2.41% |
LoseHCWB / S&P -9.68% / 5.25% |
WinHCWB / S&P 3202.86% / 6.15% |
| 2024-Q32/3 |
LoseHCWB / S&P -16.69% / 5.89% |
WinHCWB / S&P 22.27% / 5.89% |
WinHCWB / S&P 3612.50% / 6.11% |
| 2024-Q21/3 |
LoseHCWB / S&P -63.03% / 4.28% |
LoseHCWB / S&P 2.82% / 5.38% |
WinHCWB / S&P 3069.81% / 5.12% |
| 2024-Q13/3 |
WinHCWB / S&P 42.86% / 10.56% |
WinHCWB / S&P 7.68% / 5.71% |
WinHCWB / S&P 49.02% / 5.59% |
| 2023-Q41/3 |
LoseHCWB / S&P -35.53% / 11.69% |
LoseHCWB / S&P -57.72% / 6.81% |
WinHCWB / S&P 62.79% / 7.78% |
| 2023-Q31/3 |
LoseHCWB / S&P -12.44% / -3.27% |
LoseHCWB / S&P -46.86% / 7.52% |
WinHCWB / S&P 154.55% / -5.03% |
| 2023-Q22/3 |
WinHCWB / S&P 54.89% / 8.74% |
LoseHCWB / S&P 6.82% / 9.50% |
WinHCWB / S&P 112.00% / -8.57% |
| 2023-Q11/3 |
LoseHCWB / S&P -26.84% / 7.50% |
WinHCWB / S&P 16.96% / 10.77% |
LoseHCWB / S&P -37.04% / -15.69% |
| 2022-Q40/3 |
LoseHCWB / S&P -16.38% / 7.56% |
LoseHCWB / S&P HCWB unavailable / 11.88% |
LoseHCWB / S&P HCWB unavailable / -17.99% |
| 2022-Q32/3 |
WinHCWB / S&P 4.09% / -4.88% |
WinHCWB / S&P 31.24% / 13.47% |
LoseHCWB / S&P HCWB unavailable / -1.41% |
| 2022-Q20/3 |
LoseHCWB / S&P -19.41% / -16.10% |
LoseHCWB / S&P -12.88% / 13.71% |
LoseHCWB / S&P HCWB unavailable / 11.04% |
| 2022-Q11/3 |
WinHCWB / S&P 17.67% / -4.60% |
LoseHCWB / S&P -23.96% / 15.97% |
LoseHCWB / S&P HCWB unavailable / 42.23% |
| 2021-Q40/3 |
LoseHCWB / S&P -27.27% / 11.03% |
LoseHCWB / S&P HCWB unavailable / 15.00% |
LoseHCWB / S&P HCWB unavailable / 96.40% |
| 2021-Q30/3 |
LoseHCWB / S&P HCWB unavailable / 0.58% |
LoseHCWB / S&P HCWB unavailable / 10.77% |
LoseHCWB / S&P HCWB unavailable / 69.42% |
| 2021-Q20/3 |
LoseHCWB / S&P HCWB unavailable / 8.55% |
LoseHCWB / S&P HCWB unavailable / 6.58% |
LoseHCWB / S&P HCWB unavailable / 51.81% |
| 2021-Q10/3 |
LoseHCWB / S&P HCWB unavailable / 6.17% |
LoseHCWB / S&P HCWB unavailable / -1.06% |
LoseHCWB / S&P HCWB unavailable / 7.39% |
| 2020-Q40/3 |
LoseHCWB / S&P HCWB unavailable / 12.15% |
LoseHCWB / S&P HCWB unavailable / -3.72% |
LoseHCWB / S&P HCWB unavailable / -33.42% |
| 2020-Q30/3 |
LoseHCWB / S&P HCWB unavailable / 8.93% |
LoseHCWB / S&P HCWB unavailable / -2.04% |
LoseHCWB / S&P HCWB unavailable / -27.10% |
| 2020-Q20/3 |
LoseHCWB / S&P HCWB unavailable / 20.54% |
LoseHCWB / S&P HCWB unavailable / -0.46% |
LoseHCWB / S&P HCWB unavailable / -27.11% |
| 2020-Q10/3 |
LoseHCWB / S&P HCWB unavailable / -19.60% |
LoseHCWB / S&P HCWB unavailable / 3.47% |
LoseHCWB / S&P HCWB unavailable / -14.75% |
| 2019-Q40/3 |
LoseHCWB / S&P HCWB unavailable / 9.07% |
LoseHCWB / S&P HCWB unavailable / 5.36% |
LoseHCWB / S&P HCWB unavailable / 2.99% |
| 2019-Q30/3 |
LoseHCWB / S&P HCWB unavailable / 1.70% |
LoseHCWB / S&P HCWB unavailable / 5.02% |
LoseHCWB / S&P HCWB unavailable / 0.21% |
| 2019-Q20/3 |
LoseHCWB / S&P HCWB unavailable / 4.30% |
LoseHCWB / S&P HCWB unavailable / 6.64% |
LoseHCWB / S&P HCWB unavailable / 8.65% |
| 2019-Q10/3 |
LoseHCWB / S&P HCWB unavailable / 13.65% |
LoseHCWB / S&P HCWB unavailable / 8.12% |
LoseHCWB / S&P HCWB unavailable / 14.29% |
| 2018-Q40/3 |
LoseHCWB / S&P HCWB unavailable / -13.52% |
LoseHCWB / S&P HCWB unavailable / 9.05% |
LoseHCWB / S&P HCWB unavailable / 18.23% |
| 2018-Q30/3 |
LoseHCWB / S&P HCWB unavailable / 7.71% |
LoseHCWB / S&P HCWB unavailable / 10.21% |
LoseHCWB / S&P HCWB unavailable / 19.06% |
| 2018-Q20/3 |
LoseHCWB / S&P HCWB unavailable / 3.43% |
LoseHCWB / S&P HCWB unavailable / 9.03% |
LoseHCWB / S&P HCWB unavailable / 14.46% |
| 2018-Q10/3 |
LoseHCWB / S&P HCWB unavailable / -0.76% |
LoseHCWB / S&P HCWB unavailable / 7.68% |
LoseHCWB / S&P HCWB unavailable / 12.46% |
| 2017-Q40/3 |
LoseHCWB / S&P HCWB unavailable / 6.64% |
LoseHCWB / S&P HCWB unavailable / 7.03% |
LoseHCWB / S&P HCWB unavailable / 13.82% |
| 2017-Q30/3 |
LoseHCWB / S&P HCWB unavailable / 4.48% |
LoseHCWB / S&P HCWB unavailable / 5.68% |
LoseHCWB / S&P HCWB unavailable / 17.57% |
| 2017-Q20/3 |
LoseHCWB / S&P HCWB unavailable / 3.09% |
LoseHCWB / S&P HCWB unavailable / 4.83% |
LoseHCWB / S&P HCWB unavailable / 17.74% |
| 2017-Q10/3 |
LoseHCWB / S&P HCWB unavailable / 6.07% |
LoseHCWB / S&P HCWB unavailable / 3.67% |
LoseHCWB / S&P HCWB unavailable / 13.32% |
| 2016-Q40/3 |
LoseHCWB / S&P HCWB unavailable / 3.82% |
LoseHCWB / S&P HCWB unavailable / 2.09% |
LoseHCWB / S&P HCWB unavailable / 7.05% |
| 2016-Q30/3 |
LoseHCWB / S&P HCWB unavailable / 3.85% |
LoseHCWB / S&P HCWB unavailable / 0.20% |
LoseHCWB / S&P HCWB unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | HCWB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.76% | 20.78% |
| Annualized return | -90.76% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | HCWB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.66% | 83.14% |
| Annualized return | -67.97% | 12.86% |
10Y · 2021-07-20 to 2026-08-27
| Metric | HCWB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.79% | 319.30% |
| Annualized return | -46.03% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |